{"transactions":[{"id":908374,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T17:33:57.000Z","date":"2026-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":10.83,"expiration_date":"2035-07-29","underlying":"Ordinary Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-26-014444","document":"tm266121-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465926014444/tm266121-5_4seq1.xml","form_type":"4"}},{"id":908373,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T17:33:57.000Z","date":"2026-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":16.32,"expiration_date":"2034-07-30","underlying":"Ordinary Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-26-014444","document":"tm266121-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465926014444/tm266121-5_4seq1.xml","form_type":"4"}},{"id":908372,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T17:33:57.000Z","date":"2026-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":33000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":14.1,"expiration_date":"2033-08-01","underlying":"Ordinary Shares","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001104659-26-014444","document":"tm266121-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465926014444/tm266121-5_4seq1.xml","form_type":"4"}},{"id":908371,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T17:33:57.000Z","date":"2026-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":42000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":4.79,"expiration_date":"2032-08-03","underlying":"Ordinary Shares","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001104659-26-014444","document":"tm266121-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465926014444/tm266121-5_4seq1.xml","form_type":"4"}},{"id":908370,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T17:33:57.000Z","date":"2026-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":42000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":8.07,"expiration_date":"2031-08-03","underlying":"Ordinary Shares","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001104659-26-014444","document":"tm266121-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465926014444/tm266121-5_4seq1.xml","form_type":"4"}},{"id":908369,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T17:33:57.000Z","date":"2026-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":5.3,"expiration_date":"2030-09-13","underlying":"Ordinary Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-26-014444","document":"tm266121-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465926014444/tm266121-5_4seq1.xml","form_type":"4"}},{"id":908368,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T17:33:57.000Z","date":"2026-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":42000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":8.48,"expiration_date":"2030-08-07","underlying":"Ordinary Shares","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001104659-26-014444","document":"tm266121-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465926014444/tm266121-5_4seq1.xml","form_type":"4"}},{"id":908367,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T17:33:57.000Z","date":"2026-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess of the Cash Consideration over the applicable exercise price per Ordinary Share under such Option and (ii) one CVR for each Ordinary Share subject to such Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":5.92,"expiration_date":"2029-12-05","underlying":"Ordinary Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-26-014444","document":"tm266121-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465926014444/tm266121-5_4seq1.xml","form_type":"4"}},{"id":908366,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-02-12T17:33:57.000Z","date":"2026-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":67025,"price":21,"value":1407525.0,"ownership":{"direct":false,"nature":"By McCamish Charitable Remainder Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the disposition of ordinary shares of Avadel Pharmaceuticals plc (\"Issuer\"), nominal value $0.01 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement, dated as of October 22, 2025, as amended by Amendment No. 1 to the Transaction Agreement dated November 18, 2025, (together the \"Transaction Agreement\") by and between Issuer and Alkermes plc (\"Parent\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Parent acquired Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Transaction Agreement, on February 12, 2026, the effective time of the Scheme (the \"Effective Time\"), each outstanding Ordinary Share was converted into $21.00 in cash (the \"Cash Consideration\") and a non-transferable contingent value right entitling the holders to a potential additional cash payment of $1.50 per share, contingent upon achievement of certain milestones (each a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of ordinary shares of Avadel Pharmaceuticals plc (\"Issuer\"), nominal value $0.01 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement, dated as of October 22, 2025, as amended by Amendment No. 1 to the Transaction Agreement dated November 18, 2025, (together the \"Transaction Agreement\") by and between Issuer and Alkermes plc (\"Parent\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Parent acquired Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Transaction Agreement, on February 12, 2026, the effective time of the Scheme (the \"Effective Time\"), each outstanding Ordinary Share was converted into $21.00 in cash (the \"Cash Consideration\") and a non-transferable contingent value right entitling the holders to a potential additional cash payment of $1.50 per share, contingent upon achievement of certain milestones (each a \"CVR\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by McCamish Charitable Remainder Trust, of which the Reporting Person and his spouse are income beneficiaries. The Reporting Person disclaims beneficial ownership except to the extent of his and his spouse's pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-014444","document":"tm266121-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465926014444/tm266121-5_4seq1.xml","form_type":"4"}},{"id":908365,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-02-12T17:33:57.000Z","date":"2026-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22000,"price":21,"value":462000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the disposition of ordinary shares of Avadel Pharmaceuticals plc (\"Issuer\"), nominal value $0.01 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement, dated as of October 22, 2025, as amended by Amendment No. 1 to the Transaction Agreement dated November 18, 2025, (together the \"Transaction Agreement\") by and between Issuer and Alkermes plc (\"Parent\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Parent acquired Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Transaction Agreement, on February 12, 2026, the effective time of the Scheme (the \"Effective Time\"), each outstanding Ordinary Share was converted into $21.00 in cash (the \"Cash Consideration\") and a non-transferable contingent value right entitling the holders to a potential additional cash payment of $1.50 per share, contingent upon achievement of certain milestones (each a \"CVR\")."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes Ordinary Shares previously subject to vesting restrictions or forfeiture back to Issuer (each, a \"Restricted Stock Award\"). Pursuant to the Transaction Agreement, at the Effective time, each Restricted Stock Award that was outstanding immediately prior to the Effective Time vested in full and was treated in the manner described in footnote 1."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of ordinary shares of Avadel Pharmaceuticals plc (\"Issuer\"), nominal value $0.01 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement, dated as of October 22, 2025, as amended by Amendment No. 1 to the Transaction Agreement dated November 18, 2025, (together the \"Transaction Agreement\") by and between Issuer and Alkermes plc (\"Parent\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Parent acquired Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Transaction Agreement, on February 12, 2026, the effective time of the Scheme (the \"Effective Time\"), each outstanding Ordinary Share was converted into $21.00 in cash (the \"Cash Consideration\") and a non-transferable contingent value right entitling the holders to a potential additional cash payment of $1.50 per share, contingent upon achievement of certain milestones (each a \"CVR\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-014444","document":"tm266121-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465926014444/tm266121-5_4seq1.xml","form_type":"4"}},{"id":916541,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-02-06T16:10:10.000Z","date":"2026-02-04","kind":"gift","planned":false,"acquired":true,"shares":67025,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By McCamish Charitable Remainder Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 4, 2026, the Reporting Person transferred 67,025 shares from Matthew 5 LLC to the McCamish Charitable Remainder Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by McCamish Charitable Remainder Trust, of which the Reporting Person and his spouse are income beneficiaries. The Reporting Person disclaims beneficial ownership except to the extent of his and his spouse's pecuniary interest therein."}],"balance_after":67025,"source":{"system":"sec-edgar","filing":"0001104659-26-011511","document":"tm265492-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465926011511/tm265492-1_4seq1.xml","form_type":"4"}},{"id":916540,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-02-06T16:10:10.000Z","date":"2026-02-04","kind":"gift","planned":false,"acquired":false,"shares":67025,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Matthew 5 LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 4, 2026, the Reporting Person transferred 67,025 shares from Matthew 5 LLC to the McCamish Charitable Remainder Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Matthew 5 LLC. The Mark & Barbara McCamish Family Trust is the sole owner of Matthew 5 LLC, and the Reporting Person serves as its manager."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-011511","document":"tm265492-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465926011511/tm265492-1_4seq1.xml","form_type":"4"}},{"id":1078631,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-31T16:10:52.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options shall vest in full on the earlier to occur of (a) July 29, 2026 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service at such time."}],"balance_after":11000,"derivative":{"exercise_price":10.83,"expiration_date":"2035-07-29","underlying":"Ordinary Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-25-072695","document":"tm2522138-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465925072695/tm2522138-6_4seq1.xml","form_type":"4"}},{"id":1078630,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-07-31T16:10:52.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted share award. The shares shall vest in full on the earlier to occur of (a) July 29, 2026 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service at such time."}],"balance_after":22000,"source":{"system":"sec-edgar","filing":"0001104659-25-072695","document":"tm2522138-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465925072695/tm2522138-6_4seq1.xml","form_type":"4"}},{"id":1444628,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-01T16:32:04.000Z","date":"2024-07-30","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options shall vest in full on the earlier to occur of (a) July 30, 2025 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service at such time."}],"balance_after":11000,"derivative":{"exercise_price":16.32,"expiration_date":"2034-07-30","underlying":"Ordinary Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-24-084930","document":"tm2420652-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465924084930/tm2420652-2_4seq1.xml","form_type":"4"}},{"id":1444627,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-08-01T16:32:04.000Z","date":"2024-07-30","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units (\"RSUs\"). Each RSU represents the contingent right to receive one Ordinary Share upon vesting and settlement. The RSUs shall vest in full on the earlier to occur of (a) July 30, 2025 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service at such time."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001104659-24-084930","document":"tm2420652-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465924084930/tm2420652-2_4seq1.xml","form_type":"4"}},{"id":1683812,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2024-01-08T10:14:55.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":27655,"price":1.81,"value":50055.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock that vests in full immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the average closing price of the Issuer's Class B common stock during December 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of fully vested shares of Restricted Stock."}],"balance_after":60241,"source":{"system":"sec-edgar","filing":"0001209191-24-001097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390798/000120919124001097/doc4.xml","form_type":"4"}},{"id":1698183,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ADSs","published_at":"2023-12-29T16:15:39.000Z","date":"2023-12-28","kind":"sale","planned":true,"acquired":false,"shares":75000,"price":14.53,"value":1089750.0,"ownership":{"direct":false,"nature":"By Matthew 5 LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's \"ADSs\" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the Issuer; ADSs may be represented by American Depositary Receipts."},{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.50 to $14.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Matthew 5 LLC. The Mark & Barbara McCamish Family Trust is the sole owner of Matthew 5 LLC, and the Reporting Person serves as its manager."}],"balance_after":67025,"source":{"system":"sec-edgar","filing":"0001104659-23-130483","document":"tm2333942-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465923130483/tm2333942-1_4seq1.xml","form_type":"4"}},{"id":1807693,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ADSs","published_at":"2023-08-15T16:13:49.000Z","date":"2023-08-11","kind":"sale","planned":false,"acquired":false,"shares":28975,"price":14.9306,"value":432614.135,"ownership":{"direct":false,"nature":"By Matthew 5 LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's \"ADSs\" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the Issuer; ADSs\nmay be represented by American Depositary Receipts."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.75 to $15.20,\ninclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission,\nupon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Matthew 5 LLC. The Mark & Barbara McCamish Family Trust is the sole owner of Matthew 5 LLC, and the Reporting Person serves as its\nmanager."}],"balance_after":142025,"source":{"system":"sec-edgar","filing":"0001104659-23-091957","document":"tm2323851-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465923091957/tm2323851-1_4seq1.xml","form_type":"4"}},{"id":1816961,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T16:17:30.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest in full on the earlier to occur of (a) August 1, 2024 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service on the Board of Directors at such time."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Issuer's \"ADSs\" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts."}],"balance_after":33000,"derivative":{"exercise_price":14.1,"expiration_date":"2033-08-01","underlying":"ADSs","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001104659-23-087289","document":"tm2322778-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465923087289/tm2322778-3_4seq1.xml","form_type":"4"}},{"id":2061871,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2023-01-05T14:31:49.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":27174,"price":1.84,"value":50000.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock that vests in full immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the average closing price of the Issuer's Class B common stock during December 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of fully vested shares of Restricted Stock."}],"balance_after":32586,"source":{"system":"sec-edgar","filing":"0001209191-23-001686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390798/000120919123001686/doc4.xml","form_type":"4"}},{"id":2193758,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-05T17:13:47.000Z","date":"2022-08-03","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest in full on the earlier to occur of (a) August 3, 2023 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service on the Board of Directors at such time."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Issuer's \"ADSs\" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts."}],"balance_after":42000,"derivative":{"exercise_price":4.79,"expiration_date":"2032-08-03","underlying":"ADSs","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001104659-22-086772","document":"tm2222707-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465922086772/tm2222707-3_4seq1.xml","form_type":"4"}},{"id":2442987,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2022-01-05T12:34:30.000Z","date":"2022-01-05","kind":"grant","acquired":true,"shares":5412,"price":5.39,"value":29170.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock that vests in full immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the average closing price of the Issuer's Class B common stock during December 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of fully vested shares of Restricted Stock."}],"balance_after":5412,"source":{"system":"sec-edgar","filing":"0001209191-22-001452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390798/000120919122001452/doc4.xml","form_type":"4"}},{"id":2613593,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T19:28:04.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest in full on the earlier to occur of (a) August 3, 2022 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service on the Board of Directors at such time."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Issuer's \"ADSs\" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts."}],"balance_after":42000,"derivative":{"exercise_price":8.07,"expiration_date":"2031-08-03","underlying":"ADSs","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001179110-21-007965","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000117911021007965/edgar.xml","form_type":"4"}},{"id":2931531,"issuer":{"id":84409,"kind":"organization","name":"Vincerx Pharma, Inc.","symbol":"VINC"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-28T21:26:58.000Z","date":"2020-12-23","kind":"grant","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of December 23, 2021, the next annual meeting of stockholders or the consummation of a change of control, subject to the director's continued service."}],"balance_after":6667,"derivative":{"exercise_price":19,"expiration_date":"2030-12-23","underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0000899243-20-035393","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1796129/000089924320035393/doc4.xml","form_type":"4"}},{"id":3027303,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ADSs","published_at":"2020-09-18T16:20:52.000Z","date":"2020-09-17","kind":"purchase","acquired":true,"shares":52398,"price":5.8256,"value":305249.7888,"ownership":{"direct":false,"nature":"By Matthew 5 LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The issuer's \"ADSs\" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.68 to $5.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Matthew 5 LLC. The Mark & Barbara McCamish Family Trust is the sole owner of Matthew 5 LLC, and the Reporting Person serves as its manager."}],"balance_after":171000,"source":{"system":"sec-edgar","filing":"0001179110-20-009879","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000117911020009879/edgar.xml","form_type":"4"}},{"id":3027302,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ADSs","published_at":"2020-09-18T16:20:52.000Z","date":"2020-09-16","kind":"purchase","acquired":true,"shares":118602,"price":5.7332,"value":679968.9864,"ownership":{"direct":false,"nature":"By Matthew 5 LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The issuer's \"ADSs\" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.25 to $5.895, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Matthew 5 LLC. The Mark & Barbara McCamish Family Trust is the sole owner of Matthew 5 LLC, and the Reporting Person serves as its manager."}],"balance_after":118602,"source":{"system":"sec-edgar","filing":"0001179110-20-009879","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000117911020009879/edgar.xml","form_type":"4"}},{"id":3032577,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-09-14T07:17:09.000Z","date":"2020-09-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options shall vest and become exercisable in the following manner: 33% on September 13, 2021; 33% on September 13, 2022; and the remaining 34% on September 13, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The issuer's \"ADSs\" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts."}],"balance_after":50000,"derivative":{"exercise_price":5.3,"expiration_date":"2030-09-13","underlying":"ADSs","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-20-009709","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000117911020009709/edgar.xml","form_type":"4"}},{"id":3062389,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-11T16:58:04.000Z","date":"2020-08-07","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options become exercisable as to 14,000 ADSs on each of the first three anniversaries after the 08/07/2020 grant date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Issuer's \"ADSs\" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by AmericanDepositary Receipts."}],"balance_after":42000,"derivative":{"exercise_price":8.48,"expiration_date":"2020-08-07","underlying":"ADSs","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001179110-20-008893","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000117911020008893/edgar.xml","form_type":"4"}},{"id":3180673,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-07T12:11:41.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":327375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning December 13, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $19,560,656.25, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning December 13, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $19,560,656.25, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."}],"balance_after":0,"derivative":{"exercise_price":35.75,"expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":327375},"source":{"system":"sec-edgar","filing":"0001209191-20-023711","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023711/doc4.xml","form_type":"4"}},{"id":3180672,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-07T12:11:41.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":184516,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning March 1, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $16,005,379.13, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning March 1, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $16,005,379.13, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."}],"balance_after":0,"derivative":{"exercise_price":8.7575,"expiration_date":"2028-04-26","underlying":"Common Stock","underlying_shares":184516},"source":{"system":"sec-edgar","filing":"0001209191-20-023711","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023711/doc4.xml","form_type":"4"}},{"id":3180671,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-07T12:11:41.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":334239,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning November 8, 2017, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $30,158,384.97, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning November 8, 2017, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $30,158,384.97, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."}],"balance_after":0,"derivative":{"exercise_price":5.27,"expiration_date":"2027-11-27","underlying":"Common Stock","underlying_shares":334239},"source":{"system":"sec-edgar","filing":"0001209191-20-023711","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023711/doc4.xml","form_type":"4"}},{"id":3180670,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-07T12:11:41.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":134629,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning August 15, 2017, subject to the Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $12,199,743.41, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning August 15, 2017, subject to the Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $12,199,743.41, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."}],"balance_after":0,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-08-14","underlying":"Common Stock","underlying_shares":134629},"source":{"system":"sec-edgar","filing":"0001209191-20-023711","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023711/doc4.xml","form_type":"4"}},{"id":3180669,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-07T12:11:41.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":314395,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option, which provided for vesting over a four year period as follows: (i) 96,773 shares subject to the option vested on May 1, 2018, and (ii) the balance of the shares subject to the option vesting in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $28,489,688.91, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided for vesting over a four year period as follows: (i) 96,773 shares subject to the option vested on May 1, 2018, and (ii) the balance of the shares subject to the option vesting in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $28,489,688.91, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."}],"balance_after":0,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":314395},"source":{"system":"sec-edgar","filing":"0001209191-20-023711","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023711/doc4.xml","form_type":"4"}},{"id":3180668,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-07T12:11:41.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":4595,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to an agreement and plan of merger by and between the Issuer, Gilead Sciences, Inc. (\"Gilead\") and Toro Merger Sub, Inc. (\"Purchaser\") (the \"Merger\") in exchange for $95.50 per share, net to the holder in cash, without interest and subject to any withholding of taxes, upon the terms and subject to the conditions described in the Offer to Purchase dated March 10, 2020 (together with any amendments or supplements thereto, the \"Offer to Purchase\") and in the accompanying Letter of Transmittal (together with any amendments or supplements thereto), which are annexed to and filed with the Schedule TO as Exhibits (a)(1)(A) and (a)(1)(B), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to an agreement and plan of merger by and between the Issuer, Gilead Sciences, Inc. (\"Gilead\") and Toro Merger Sub, Inc. (\"Purchaser\") (the \"Merger\") in exchange for $95.50 per share, net to the holder in cash, without interest and subject to any withholding of taxes, upon the terms and subject to the conditions described in the Offer to Purchase dated March 10, 2020 (together with any amendments or supplements thereto, the \"Offer to Purchase\") and in the accompanying Letter of Transmittal (together with any amendments or supplements thereto), which are annexed to and filed with the Schedule TO as Exhibits (a)(1)(A) and (a)(1)(B), respectively."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-023711","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023711/doc4.xml","form_type":"4"}},{"id":3183463,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-03T17:50:41.000Z","date":"2020-04-01","kind":"exercise","acquired":false,"shares":27,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in a series of 48 successive equal monthly installments beginning August 15, 2017, subject to the Reporting Person's continuous service as of each such date.  The shares subject to this option may be exercised prior to vesting, subject to the Issuer's right to repurchase."}],"balance_after":134629,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-08-14","underlying":"Common Stock","underlying_shares":27},"source":{"system":"sec-edgar","filing":"0001209191-20-023385","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023385/doc4.xml","form_type":"4"}},{"id":3183462,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-03T17:50:41.000Z","date":"2020-04-01","kind":"exercise","acquired":false,"shares":30210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"96,773 shares subject to the option vested on May 1, 2018 and the balance of the shares subject to the option vest in a series of 36 successive equal monthly installments beginning June 1, 2018, subject to the Reporting Person's continuous service as of each such date."}],"balance_after":314395,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":30210},"source":{"system":"sec-edgar","filing":"0001209191-20-023385","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023385/doc4.xml","form_type":"4"}},{"id":3183461,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-03T17:50:41.000Z","date":"2020-04-01","kind":"sale","acquired":false,"shares":30237,"price":95.4207,"value":2885235.7059,"ownership":{"direct":true},"balance_after":4595,"source":{"system":"sec-edgar","filing":"0001209191-20-023385","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023385/doc4.xml","form_type":"4"}},{"id":3183460,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-03T17:50:41.000Z","date":"2020-04-01","kind":"sale","acquired":false,"shares":2340,"price":95.4138,"value":223268.292,"ownership":{"direct":true},"balance_after":34832,"source":{"system":"sec-edgar","filing":"0001209191-20-023385","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023385/doc4.xml","form_type":"4"}},{"id":3183459,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-03T17:50:41.000Z","date":"2020-04-01","kind":"exercise","acquired":true,"shares":30237,"price":4.8825,"value":147632.1525,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,935 shares acquired under the Forty Seven, Inc. 2018 Employee Stock Purchase Plan."}],"balance_after":37172,"source":{"system":"sec-edgar","filing":"0001209191-20-023385","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023385/doc4.xml","form_type":"4"}},{"id":3183458,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-03T17:50:41.000Z","date":"2020-03-16","kind":"gift","acquired":false,"shares":60719,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-023385","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023385/doc4.xml","form_type":"4"}},{"id":3339020,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-17T19:23:47.000Z","date":"2019-12-13","kind":"grant","acquired":true,"shares":327375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in a series of 48 successive equal monthly installments beginning with the vesting commencement date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":327375,"derivative":{"exercise_price":35.75,"expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":327375},"source":{"system":"sec-edgar","filing":"0001209191-19-061039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119061039/doc4.xml","form_type":"4"}},{"id":3348627,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-09T21:24:23.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options shall vest and become exercisable in the following manner: 33% on December 5, 2020; 33% on December 5, 2021; and the remaining 34% on December 5, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The issuer's \"ADSs\" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts."}],"balance_after":60000,"derivative":{"exercise_price":5.92,"expiration_date":"2019-12-05","underlying":"ADSs","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001179110-19-012567","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1012477/000117911019012567/edgar.xml","form_type":"4"}},{"id":3476901,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-27T18:22:12.000Z","date":"2019-06-25","kind":"exercise","acquired":false,"shares":8199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to the option vested on May 1, 2018 and the balance of the shares subject to the option vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such date."}],"balance_after":344605,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":8199},"source":{"system":"sec-edgar","filing":"0001209191-19-039347","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119039347/doc4.xml","form_type":"4"}},{"id":3476900,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-06-27T18:22:12.000Z","date":"2019-06-25","kind":"sale","acquired":false,"shares":8199,"price":11.0246,"value":90390.6954,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.00 to $11.20, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":60719,"source":{"system":"sec-edgar","filing":"0001209191-19-039347","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119039347/doc4.xml","form_type":"4"}},{"id":3476899,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-06-27T18:22:12.000Z","date":"2019-06-25","kind":"exercise","acquired":true,"shares":8199,"price":4.8825,"value":40031.6175,"ownership":{"direct":true},"balance_after":68918,"source":{"system":"sec-edgar","filing":"0001209191-19-039347","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119039347/doc4.xml","form_type":"4"}},{"id":3480225,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-24T17:39:08.000Z","date":"2019-06-20","kind":"exercise","acquired":false,"shares":8301,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to the option vested on May 1, 2018 and the balance of the shares subject to the option vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such date."}],"balance_after":352804,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":8301},"source":{"system":"sec-edgar","filing":"0001209191-19-038824","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119038824/doc4.xml","form_type":"4"}},{"id":3480224,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-06-24T17:39:08.000Z","date":"2019-06-20","kind":"sale","acquired":false,"shares":8301,"price":11.038,"value":91626.438,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.00 to $11.20, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":60719,"source":{"system":"sec-edgar","filing":"0001209191-19-038824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119038824/doc4.xml","form_type":"4"}},{"id":3480223,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-06-24T17:39:08.000Z","date":"2019-06-20","kind":"exercise","acquired":true,"shares":8301,"price":4.8825,"value":40529.6325,"ownership":{"direct":true},"balance_after":69020,"source":{"system":"sec-edgar","filing":"0001209191-19-038824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119038824/doc4.xml","form_type":"4"}},{"id":3515375,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-05-22T20:15:10.000Z","date":"2019-05-20","kind":"exercise","acquired":false,"shares":1291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to the option vested on May 1, 2018 and the balance of the shares subject to the option vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such date."}],"balance_after":361105,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":1291},"source":{"system":"sec-edgar","filing":"0001209191-19-032180","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119032180/doc4.xml","form_type":"4"}},{"id":3515374,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-05-22T20:15:10.000Z","date":"2019-05-20","kind":"exercise","acquired":false,"shares":15209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to the option vested on May 1, 2018 and the balance of the shares subject to the option vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such date."}],"balance_after":362396,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":15209},"source":{"system":"sec-edgar","filing":"0001209191-19-032180","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119032180/doc4.xml","form_type":"4"}},{"id":3515373,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-22T20:15:10.000Z","date":"2019-05-20","kind":"sale","acquired":false,"shares":1291,"price":12.4555,"value":16080.0505,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.42 to $12.49, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":60719,"source":{"system":"sec-edgar","filing":"0001209191-19-032180","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119032180/doc4.xml","form_type":"4"}},{"id":3515372,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-22T20:15:10.000Z","date":"2019-05-20","kind":"exercise","acquired":true,"shares":1291,"price":4.8825,"value":6303.3075,"ownership":{"direct":true},"balance_after":62010,"source":{"system":"sec-edgar","filing":"0001209191-19-032180","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119032180/doc4.xml","form_type":"4"}},{"id":3515371,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-22T20:15:10.000Z","date":"2019-05-20","kind":"sale","acquired":false,"shares":15209,"price":12.0748,"value":183645.6332,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.38 to $12.36, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":60719,"source":{"system":"sec-edgar","filing":"0001209191-19-032180","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119032180/doc4.xml","form_type":"4"}},{"id":3515370,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-22T20:15:10.000Z","date":"2019-05-20","kind":"exercise","acquired":true,"shares":15209,"price":4.8825,"value":74257.9425,"ownership":{"direct":true},"balance_after":75928,"source":{"system":"sec-edgar","filing":"0001209191-19-032180","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119032180/doc4.xml","form_type":"4"}},{"id":3551452,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-22T20:21:51.000Z","date":"2019-04-18","kind":"exercise","acquired":false,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to the option vested on May 1, 2018 and the balance of the shares subject to the option vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such date."}],"balance_after":377605,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-19-025558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119025558/doc4.xml","form_type":"4"}},{"id":3551451,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-04-22T20:21:51.000Z","date":"2019-04-18","kind":"sale","acquired":false,"shares":16500,"price":18.1245,"value":299054.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $17.58 to $18.69, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":60719,"source":{"system":"sec-edgar","filing":"0001209191-19-025558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119025558/doc4.xml","form_type":"4"}},{"id":3551450,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-04-22T20:21:51.000Z","date":"2019-04-18","kind":"exercise","acquired":true,"shares":16500,"price":4.8825,"value":80561.25,"ownership":{"direct":true},"balance_after":77219,"source":{"system":"sec-edgar","filing":"0001209191-19-025558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119025558/doc4.xml","form_type":"4"}},{"id":3583037,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-21T20:42:42.000Z","date":"2019-03-19","kind":"exercise","acquired":false,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"96,773 shares subject to the original option vested on May 1, 2018 and the balance of the shares subject to the option vest in a series of 36 successive equal monthly installments beginning June 1, 2018, subject to the Reporting Person's continuous service as of each such date."}],"balance_after":394105,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-19-020886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119020886/doc4.xml","form_type":"4"}},{"id":3583036,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-03-21T20:42:42.000Z","date":"2019-03-19","kind":"sale","acquired":false,"shares":16500,"price":18.1455,"value":299400.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $17.45 to $18.40, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":60719,"source":{"system":"sec-edgar","filing":"0001209191-19-020886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119020886/doc4.xml","form_type":"4"}},{"id":3583035,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-03-21T20:42:42.000Z","date":"2019-03-19","kind":"exercise","acquired":true,"shares":16500,"price":4.8825,"value":80561.25,"ownership":{"direct":true},"balance_after":77219,"source":{"system":"sec-edgar","filing":"0001209191-19-020886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119020886/doc4.xml","form_type":"4"}},{"id":3641952,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-21T19:51:45.000Z","date":"2019-02-20","kind":"exercise","acquired":false,"shares":9410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"96,773 shares subject to the original option vested on May 1, 2018 and the balance of the shares subject to the option vest in a series of 36 successive equal monthly installments beginning June 1, 2018, subject to the Reporting Person's continuous service as of each such date."}],"balance_after":410605,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":9410},"source":{"system":"sec-edgar","filing":"0001209191-19-012325","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119012325/doc4.xml","form_type":"4"}},{"id":3641951,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-21T19:51:45.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":7090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"96,773 shares subject to the original option vested on May 1, 2018 and the balance of the shares subject to the option vest in a series of 36 successive equal monthly installments beginning June 1, 2018, subject to the Reporting Person's continuous service as of each such date."}],"balance_after":420015,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":7090},"source":{"system":"sec-edgar","filing":"0001209191-19-012325","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119012325/doc4.xml","form_type":"4"}},{"id":3641950,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-02-21T19:51:45.000Z","date":"2019-02-20","kind":"sale","acquired":false,"shares":9410,"price":14.9358,"value":140545.878,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.45 to $15.27, inclusive."}],"balance_after":60719,"source":{"system":"sec-edgar","filing":"0001209191-19-012325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119012325/doc4.xml","form_type":"4"}},{"id":3641949,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-02-21T19:51:45.000Z","date":"2019-02-20","kind":"exercise","acquired":true,"shares":9410,"price":4.8825,"value":45944.325,"ownership":{"direct":true},"balance_after":70129,"source":{"system":"sec-edgar","filing":"0001209191-19-012325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119012325/doc4.xml","form_type":"4"}},{"id":3641948,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-02-21T19:51:45.000Z","date":"2019-02-19","kind":"sale","acquired":false,"shares":7090,"price":15.063,"value":106796.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.90 to $15.62, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 and 4."}],"balance_after":60719,"source":{"system":"sec-edgar","filing":"0001209191-19-012325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119012325/doc4.xml","form_type":"4"}},{"id":3641947,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-02-21T19:51:45.000Z","date":"2019-02-19","kind":"exercise","acquired":true,"shares":7090,"price":4.8825,"value":34616.925,"ownership":{"direct":true},"balance_after":67809,"source":{"system":"sec-edgar","filing":"0001209191-19-012325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119012325/doc4.xml","form_type":"4"}},{"id":3683867,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-29T19:38:05.000Z","date":"2019-01-25","kind":"exercise","acquired":false,"shares":20454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in a series of 48 successive equal monthly installments beginning August 15, 2017, subject to the Reporting Person's continuous service as of each such date. The shares subject to this option may be exercised prior to vesting, subject to the Issuer's right to repurchase."}],"balance_after":134656,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-08-14","underlying":"Common Stock","underlying_shares":20454},"source":{"system":"sec-edgar","filing":"0001209191-19-005940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119005940/doc4.xml","form_type":"4"}},{"id":3683866,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-29T19:38:05.000Z","date":"2019-01-25","kind":"exercise","acquired":false,"shares":31233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"96,773 shares subject to the option vested on May 1, 2018 and the balance of the shares subject to the option vest in a series of 36 successive equal monthly installments beginning June 1, 2018, subject to the Reporting Person's continuous service as of each such date."}],"balance_after":427105,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":31233},"source":{"system":"sec-edgar","filing":"0001209191-19-005940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119005940/doc4.xml","form_type":"4"}},{"id":3683865,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-29T19:38:05.000Z","date":"2019-01-25","kind":"exercise","acquired":true,"shares":20454,"price":4.8825,"value":99866.655,"ownership":{"direct":true},"balance_after":60719,"source":{"system":"sec-edgar","filing":"0001209191-19-005940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119005940/doc4.xml","form_type":"4"}},{"id":3683864,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-29T19:38:05.000Z","date":"2019-01-25","kind":"exercise","acquired":true,"shares":31233,"price":4.8825,"value":152495.1225,"ownership":{"direct":true},"balance_after":40265,"source":{"system":"sec-edgar","filing":"0001209191-19-005940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119005940/doc4.xml","form_type":"4"}},{"id":3689477,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to purchase)","published_at":"2019-01-23T19:42:04.000Z","date":"2019-01-18","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest in a series of 48 successive equal monthly installments beginning August 15, 2017, subject to the Reporting Person's continuous service as of each such date. The shares subject to this option may be exercised prior to vesting, subject to the Issuer's right to repurchase."}],"balance_after":155110,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-08-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001209191-19-005057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119005057/doc4.xml","form_type":"4"}},{"id":3689476,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-23T19:42:04.000Z","date":"2019-01-18","kind":"exercise","acquired":false,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"96,773 shares subject to the option vested on May 1, 2018 and the balance of the shares subject to the option vest in a series of 36 successive equal monthly installments beginning June 1, 2018, subject to the Reporting Person's continuous service as of each such date."}],"balance_after":458338,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-19-005057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119005057/doc4.xml","form_type":"4"}},{"id":3689475,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-23T19:42:04.000Z","date":"2019-01-18","kind":"sale","acquired":false,"shares":20000,"price":14.5946,"value":291892.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.33 to $15.28, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":9032,"source":{"system":"sec-edgar","filing":"0001209191-19-005057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119005057/doc4.xml","form_type":"4"}},{"id":3689474,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-23T19:42:04.000Z","date":"2019-01-18","kind":"exercise","acquired":true,"shares":3500,"price":4.8825,"value":17088.75,"ownership":{"direct":true},"balance_after":29032,"source":{"system":"sec-edgar","filing":"0001209191-19-005057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119005057/doc4.xml","form_type":"4"}},{"id":3689473,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-23T19:42:04.000Z","date":"2019-01-18","kind":"exercise","acquired":true,"shares":16500,"price":4.8825,"value":80561.25,"ownership":{"direct":true},"balance_after":25532,"source":{"system":"sec-edgar","filing":"0001209191-19-005057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119005057/doc4.xml","form_type":"4"}},{"id":3716902,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-28T17:37:30.000Z","date":"2018-12-26","kind":"exercise","acquired":false,"shares":2968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vest in a series of 48 successive equal monthly installments beginning August 15, 2017, subject to the Reporting Person's continuous service as of each such date.  The shares subject to this option may be exercised prior to vesting, subject to the Issuer's right to repurchase."}],"balance_after":158610,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-08-14","underlying":"Common Stock","underlying_shares":2968},"source":{"system":"sec-edgar","filing":"0001209191-18-064343","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919118064343/doc4.xml","form_type":"4"}},{"id":3716901,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-28T17:37:30.000Z","date":"2018-12-26","kind":"exercise","acquired":false,"shares":9032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"96,773 shares subject to the option vested on May 1, 2018 and the balance of the shares subject to the option vest in a series of 36 successive equal monthly installments beginning June 1, 2018, subject to the Reporting Person's continuous service as of each such date."}],"balance_after":474838,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":9032},"source":{"system":"sec-edgar","filing":"0001209191-18-064343","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919118064343/doc4.xml","form_type":"4"}},{"id":3716900,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-28T17:37:30.000Z","date":"2018-12-26","kind":"sale","acquired":false,"shares":2968,"price":15.8895,"value":47160.036,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $15.28 to $16.41, inclusive."}],"balance_after":9032,"source":{"system":"sec-edgar","filing":"0001209191-18-064343","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919118064343/doc4.xml","form_type":"4"}},{"id":3716899,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-28T17:37:30.000Z","date":"2018-12-26","kind":"sale","acquired":false,"shares":9032,"price":15.9041,"value":143645.8312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $15.35 to $16.50, inclusive.  The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4"}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001209191-18-064343","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919118064343/doc4.xml","form_type":"4"}},{"id":3716898,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-28T17:37:30.000Z","date":"2018-12-26","kind":"exercise","acquired":true,"shares":2968,"price":4.8825,"value":14491.26,"ownership":{"direct":true},"balance_after":21032,"source":{"system":"sec-edgar","filing":"0001209191-18-064343","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919118064343/doc4.xml","form_type":"4"}},{"id":3716897,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":66777,"kind":"person","name":"McCamish Mark Anthony","position":1,"cik":"0001390798","reported_name":"McCamish Mark Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-28T17:37:30.000Z","date":"2018-12-26","kind":"exercise","acquired":true,"shares":9032,"price":4.8825,"value":44098.74,"ownership":{"direct":true},"balance_after":18064,"source":{"system":"sec-edgar","filing":"0001209191-18-064343","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919118064343/doc4.xml","form_type":"4"}}]}